The market is segmented based on , By Type (Seasonal, Perennial, and Occupational Rhinitis), Treatment (Immunotherapy, Antihistamines, Decongestants, Vertebral Fusion, Corticosteroids, and Others), Route of Administration (Oral, Parenteral, and Intranasal), Form (Solid and Liquid), Test (Skin Test, IgE RAST Test, and Complete Blood Count), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores) – Industry Trends and Forecast to 2030.
.
The Global Allergic Rhinitis Market size was valued at USD 12.00 USD Billion in 2022.
The Global Allergic Rhinitis Market is projected to grow at a CAGR of 3.65% during the forecast period of 2023 to 2030.
The major players operating in the market include Merck KGaA , GSK group of companies , Sanofi , Cigna , Himalaya Wellness , Janssen PharmaceuticalsInc. , FAES Farma SA , Hisamitsu Pharmaceutical Co.Inc. , Glenmark Pharmaceuticals , Olainfarm , Boehringer Ingelheim International GmbH Covis Pharma , Teva Pharmaceutical Industries Ltd. , Sandoz International GmbH , ALK-Abello A/S Meda AB , and Bayer AG .
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, rest of Middle East and Africa) .
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.